David Domzalski
Chief Executive Officer at VYNE THERAPEUTICS INC.
Net worth: 1 M $ as of 29/04/2024
David Domzalski active positions
Companies | Position | Start | End |
---|---|---|---|
VYNE THERAPEUTICS INC. | Director/Board Member | 29/02/2020 | - |
Chief Executive Officer | 29/02/2020 | - | |
President | 29/02/2020 | - |
Career history of David Domzalski
Former positions of David Domzalski
Companies | Position | Start | End |
---|---|---|---|
VYNE Pharmaceuticals Ltd.
VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | Director/Board Member | 02/01/2018 | 08/03/2020 |
Chief Executive Officer | 28/06/2017 | 08/03/2020 | |
President | 31/03/2014 | 28/06/2017 | |
Leo Pharma, Inc.
Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | Sales & Marketing | 01/03/2011 | 30/06/2013 |
Jazz Pharmaceuticals Commercial Corp.
Jazz Pharmaceuticals Commercial Corp. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals Commercial Corp. provides pharmaceutical services. It engages in identifying, developing, and commercializing products in the areas of CNS, women's health, and urology. The company was founded in 2005 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | 31/12/2007 | 31/12/2008 |
Warner Chilcott, Inc.
Warner Chilcott, Inc. Pharmaceuticals: MajorHealth Technology Warner Chilcott, Inc. develops and manufactures drugs. It makes women's health care and urology prescription drugs, dermatology and cardiology drugs. The company is headquartered in Rockaway, NJ. | Sales & Marketing | 31/12/2002 | 31/12/2007 |
VYNE THERAPEUTICS INC. | Director/Board Member | 08/03/2020 | - |
Chief Executive Officer | 08/03/2020 | - | |
President | 08/03/2020 | - | |
Sanofi-Synthelabo, Inc. | Corporate Officer/Principal | - | - |
Training of David Domzalski
Muhlenberg College | Undergraduate Degree |
Statistics
International
United States | 8 |
Israel | 2 |
Operational
Director/Board Member | 3 |
Chief Executive Officer | 3 |
President | 3 |
Sectoral
Health Technology | 7 |
Retail Trade | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
VYNE THERAPEUTICS INC. | Health Technology |
Private companies | 6 |
---|---|
Leo Pharma, Inc.
Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | Retail Trade |
Jazz Pharmaceuticals Commercial Corp.
Jazz Pharmaceuticals Commercial Corp. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals Commercial Corp. provides pharmaceutical services. It engages in identifying, developing, and commercializing products in the areas of CNS, women's health, and urology. The company was founded in 2005 and is headquartered in Philadelphia, PA. | Health Technology |
Warner Chilcott, Inc.
Warner Chilcott, Inc. Pharmaceuticals: MajorHealth Technology Warner Chilcott, Inc. develops and manufactures drugs. It makes women's health care and urology prescription drugs, dermatology and cardiology drugs. The company is headquartered in Rockaway, NJ. | Health Technology |
Sanofi-Synthelabo, Inc. | Health Technology |
VYNE Pharmaceuticals Ltd.
VYNE Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel. | Health Technology |
Menlo Therapeutics, Inc.
Menlo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Menlo Therapeutics Inc. operates as biopharmaceutical company which is focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis. The company was founded by Ed F. Schnipper in October, 2011 and is headquartered in Bridgewater, CA. | Health Technology |
- Stock Market
- Insiders
- David Domzalski
- Experience